What does MUC — research and development expense mean?

This metric represents the total operating costs directly attributable to research and development activities within the MUC business segment. It encompasses expenditures related to drug discovery, preclinical studies, and clinical trial execution for programs managed under this specific operational unit. Tracking these expenses provides insight into the company's investment intensity and progress toward commercializing its precision medicine pipeline.

Tyra Biosciences, Inc. TYRA MUC — Research And Development Expense

Other segment segments

Personnel Costs

$11.79M+46.9%

IRNMIBC

$5.25M+307%

ACH

$4.31M+20.1%

FGFR Discovery

$2.53M-19.2%

LGUTUC

$2.44M—

Facilities And Other Costs

$1.63M+16.3%

Other Development Programs

$849K+65.2%

Similar metrics at other companies

ADPTMrd Business — Research And Development Expense

$9.23M+0.7%

MUCMBU — R&D

$536M+105%

IRONOther Research — Research And Development Expense

$2.17M+18.2%

BCRXResearch, discovery and preclinical programs — Research and Development Expense (Excluding Acquired in Process Cost)

$3.97M+30.4%

MUMCBU — R&D

$126M-46.6%

NRIXReportable Segment — R&D

$84.14M+20.8%

Other financials

Income statement

See full

Operating income-$42.0M-31.9%

Net income-$39.3M-39.6%

EPS (diluted)-$0.64-36.2%

Balance sheet

See full

Cash & equivalents$85.0M-15.7%

Total debt$5.7M-6.9%

Total equity$387.6M+19.8%

Total assets$412.0M+20.0%

Cash flow

See full

Operating cash flow-$32.6M-27.9%

CapEx$88.0K+529%

Free cash flow-$32.7M-28.2%

Valuation

See full

Market cap$1.79B+318%

Enterprise value$1.71B+397%

Returns & leverage

See full

Return on equity-36.9%+21.1pp

Debt / equity0×0.0×

Current ratio20.5×-2.3×

Where this comes from

Reported directly by Tyra Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tyra Biosciences, Inc.'s muc — research and development expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tyra Biosciences, Inc.'s MUC — research and development expense?: Tyra Biosciences, Inc. (TYRA) reported MUC — research and development expense of $1.61M in Q1 2026.
What does MUC — research and development expense mean?: This metric represents the total operating costs directly attributable to research and development activities within the MUC business segment. It encompasses expenditures related to drug discovery, preclinical studies, and clinical trial execution for programs managed under this specific operational unit. Tracking these expenses provides insight into the company's investment intensity and progress toward commercializing its precision medicine pipeline.